Innovation is at the core of what we do
We are a molecular life science company dedicated to advancing human health through innovation. By designing and building breakthrough molecular platforms that are both accessible and best-in-class, One BioMed is providing biomedical researchers and clinicians with unprecedented access to cutting-edge tools.
One BioMed featured in HolonIQ’s Top 50 Southeast Asian Health Tech Companies for 2022.
One BioMed launches the cartridge-based Xceler8™ Nucleic Acid Extraction Platform, the next generation in workflow simplification.
Southeast Asia’s top 50 rising women in tech 2021
Innovating a diagnostic device that detects infectious diseases within 30 minutes
PULSE by Maeil Business News Korea
JW Bioscience invests in Singapore’s molecular diagnostic firm One BioMed
One BioMed offers cutting-edge medical diagnostic platform
Healthcare Startup One BioMed closes $5M Series A
Asian Scientist Magazine
One kit to test for 20 diseases In 20 minutes
One BioMed & A*STAR launch $9M joint lab to make diagnostic kit for infectious diseases
Biotech expected to be key driver of future economy